Skyscape Web Viewer : Davis's Drug Guide for Nurses : Pharmacologic Index

View All
macrolides clarithromycin fidaxomicin azithromycin erythromycin
meglitinides nateglinide repaglinide
melanocortin receptor agonists afamelanotide setmelanotide bremelanotide
melatonin receptor agonists tasimelteon ramelteon
microsomal transfer protein inhibitors
minerals electrolytes fluoride supplements magnesium sulfate (parenteral)
monamine oxidase inhibitors isocarboxazid tranylcypromine phenelzine
monoamine oxidase type b inhibitors safinamide rasagiline selegiline
monobactams
monoclonal antibodies alemtuzumab amivantamab atezolizumab axatilimab belimumab bevacizumab bimekizumab burosumab cemiplimab cetuximab crizanlizumab daratumumab denosumab donanemab durvalumab elranatamab emicizumab erenumab fam-trastuzumab deruxtecan fremanezumab adalimumab alirocumab anifrolumab avelumab basiliximab benralizumab bezlotoxumab blinatumomab caplacizumab certolizumab concizumab crovalimab daratumumab/hyaluronidase dinutuximab dostarlimab elotuzumab emapalumab eptinezumab evolocumab faricimab galcanezumab golimumab ibritumomab inebilizumab ipilimumab lanadelumab lecanemab margetuximab mogamulizumab naxitamab nirsevimab obinutuzumab ofatumumab palivizumab pertuzumab polatuzumab vedotin ravulizumab risankizumab rituximab/hyaluronidase satralizumab tafasitamab teplizumab tezepelumab trastuzumab tremelimumab ustekinumab vilobelimab gemtuzumab ozogamicin guselkumab idarucizumab infliximab isatuximab lebrikizumab loncastuximab tesirine mepolizumab natalizumab necitumumab nivolumab ocrelizumab omalizumab pembrolizumab pertuzumab/trastuzumab/hyaluronidase ranibizumab reslizumab rituximab rozanolixizumab secukinumab talquetamab teprotumumab tildrakizumab trastuzumab/hyaluronidase ublituximab vedolizumab
mast cell stabilizers
metabolic inhibitors
mineralocorticoid receptor antagonists non steroidal
monoclonal anti-toxins raxibacumab obiltoxaximab
muscarinic agonists